Expertise in
34
conditions

Dr. George Z. Fadda

Nephrology
Balboa Nephrology-La Mesa
8851 Center Dr Ste 505, 
La Mesa, CA 
Offers Telehealth
Expertise in
34
conditions
Balboa Nephrology-La Mesa
8851 Center Dr Ste 505, 
La Mesa, CA 

Overview

George Fadda is a Nephrologist practicing medicine in La Mesa, California.

Dr. Fadda is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Diabetic Nephropathy, Renovascular Hypertension, Acute Tubular Necrosis, Nephrosclerosis, and Endoscopy.

He is actively involved in clinical research, co-authoring 5 peer reviewed articles and participating in 7 clinical trials.

Specialties

Nephrology

Licenses

Internal Medicine in CA

Hospital Affiliations

Grossmont Hospital
Uc San Diego Health Hillcrest - Hillcrest Med Ctr
Sharp Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Balboa Nephrology-La Mesa
8851 Center Dr Ste 505, La Mesa, CA 91942
Other Locations
Balboa Research-La Mesa
5965 Severin Dr, La Mesa, CA 91942

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
A Multi-Center, Randomized, Two-Cohort Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of CTAP101 (Calcifediol) Extended-Release Capsules to Treat Secondary Hyperparathyroidism in Subjects With Vitamin D Insufficiency and Chronic Kidney Disease Requiring Regular Hemodialysis.
Enrollment Status: Terminated
Publish Date: April 03, 2026
Intervention Type: Drug
Study Drug: Calcifediol
Study Phase: Phase 2
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 2 Trial to Evaluate Safety, Tolerability, and Efficacy of Bardoxolone Methyl in Patients With Chronic Kidney Disease at Risk of Rapid Progression
A Phase 2 Trial to Evaluate Safety, Tolerability, and Efficacy of Bardoxolone Methyl in Patients With Chronic Kidney Disease at Risk of Rapid Progression
Enrollment Status: Completed
Publish Date: June 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects With Autosomal Dominant Polycystic Kidney Disease
A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Drug
Study Drug: Tesevatinib
Study Phase: Phase 2
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
A Phase 1b, Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RGLS4326 Administered Via SC Injection to Patients With Autosomal Dominant Polycystic Kidney Disease
Enrollment Status: Completed
Publish Date: December 15, 2021
Intervention Type: Drug
Study Drug: RGLS4326
Study Phase: Phase 1
View 6 Less Clinical Trials

5 Total Publications

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Journal: Kidney360
Published: April 17, 2026
Similar Doctors
Expertise in
31
conditions
Dr. Guy L. Lund
Nephrology
Expertise in
31
conditions
Dr. Guy L. Lund
Nephrology
Referral may be required

Sharp Kidney Care/ Kidney & Pancreas Transplant And Hepatobiliary Clinic

8010 Frost St Ste 100, 
San Diego, CA 
 (7.6 miles away)
858-650-5000
Languages Spoken:
English
See accepted insurances

Guy Lund is a Nephrologist practicing medicine in San Diego, California. Dr. Lund is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Poststreptococcal Glomerulonephritis, Autosomal Dominant Polycystic Kidney Disease, Frasier Syndrome, and Diffuse Mesangial Sclerosis.

Expertise in
35
conditions
Dr. Luan K. Do
Nephrology
Expertise in
35
conditions
Dr. Luan K. Do
Nephrology
Referral may be required

Balboa Nephrology-La Mesa

8851 Center Dr Ste 505, 
La Mesa, CA 
 (0.1 miles away)
619-461-3880
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Luan Do is a Nephrologist practicing medicine in La Mesa, California. Dr. Do is highly rated in 35 conditions, according to our data. His clinical expertise encompasses End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, and Acute Tubular Necrosis.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required

Balboa Nephrology Medical Group

655 Euclid Ave Ste 303, 
National City, CA 
 (9.2 miles away)
619-475-4900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tagumpay Sacamay is a Nephrologist practicing medicine in National City, California. Dr. Sacamay is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and High Potassium Level.

Frequently Asked Questions about Dr. George Z. Fadda

How do I make an appointment with Dr. George Z. Fadda?

You can book an appointment with Dr. George Z. Fadda by calling their office at 619-461-3880. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. George Z. Fadda a top-rated expert for Diabetic Nephropathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. George Z. Fadda is classified as an Distinguished expert for Diabetic Nephropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. George Z. Fadda specialize in?

While Dr. George Z. Fadda is a Nephrology, they have specific expertise in Diabetic Nephropathy, Renovascular Hypertension, and Acute Tubular Necrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nephrology.

Does Dr. George Z. Fadda participate in research or clinical trials?

Yes. Dr. George Z. Fadda has published 5 articles and abstracts on conditions like Diabetic Nephropathy. You can view a list of Dr. George Z. Fadda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. George Z. Fadda accept my insurance?

Dr. George Z. Fadda accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 619-461-3880 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fadda's expertise for a condition
ConditionClose
    View All 11 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 53 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile